These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10689211

  • 1. International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis.
    Van Herwaarden CL, Langan CE, Siemon G, Rudolph C, Keyserling CH, Nemeth MA, Tack KJ.
    Int J Infect Dis; 2000; 4(1):26-33. PubMed ID: 10689211
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, Giguere G, Collins JJ.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
    [Abstract] [Full Text] [Related]

  • 3. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S, McCarty J, Farkas S, Drehobl M, Tosiello R, Shan M, Aneiro L, Kowalsky S.
    Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024
    [Abstract] [Full Text] [Related]

  • 4. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
    Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, Giguere G, Collins JJ.
    Clin Ther; 1995 Oct; 17(5):861-74. PubMed ID: 8595638
    [Abstract] [Full Text] [Related]

  • 5. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
    Weiss LR.
    Clin Ther; 2002 Sep; 24(9):1414-25. PubMed ID: 12380633
    [Abstract] [Full Text] [Related]

  • 6. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
    Paster RZ, McAdoo MA, Keyserling CH, Nemeth MA, Tack KJ, Griffin TJ.
    Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
    [Abstract] [Full Text] [Related]

  • 7. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
    Shah PM, Maesen FP, Dolmann A, Vetter N, Fiss E, Wesch R.
    J Antimicrob Chemother; 1999 Apr; 43(4):529-39. PubMed ID: 10350383
    [Abstract] [Full Text] [Related]

  • 8. Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime.
    Zuck P, Petitpretz P, Geslin P, Rio Y, Leblanc F.
    Int J Clin Pract; 1999 Sep; 53(6):437-43. PubMed ID: 10622071
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of cefdinir in the treatment of patients with acute bronchitis. The Cefdinir Bronchitis Study Group.
    Sperling MJ, Puopolo A, Griffin TJ, Keyserling CH, Tack KJ.
    Clin Ther; 1996 Sep; 18(4):626-34. PubMed ID: 8879891
    [Abstract] [Full Text] [Related]

  • 10. Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil.
    Alvarez-Sala JL, Kardos P, Martínez-Beltrán J, Coronel P, Aguilar L.
    Antimicrob Agents Chemother; 2006 May; 50(5):1762-7. PubMed ID: 16641447
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
    Matthys H, de Mey C, Carls C, Ryś A, Geib A, Wittig T.
    Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153
    [Abstract] [Full Text] [Related]

  • 12. Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis.
    Zervos MJ, Heyder AM, Leroy B.
    J Int Med Res; 2003 Aug; 31(3):157-69. PubMed ID: 12870368
    [Abstract] [Full Text] [Related]

  • 13. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM, Scott LJ.
    Drugs; 2004 Aug; 64(13):1433-64. PubMed ID: 15212560
    [Abstract] [Full Text] [Related]

  • 14. Clinical Comparison of Cefuroxime Axetil with Cefixime in the Treatment of Acute Bronchitis.
    Arthur M, McAdoo M, Guerra J, Maloney R, McCluskey D, Giguere G, Gomez G, Collins JJ.
    Am J Ther; 1996 Sep; 3(9):622-629. PubMed ID: 11862302
    [Abstract] [Full Text] [Related]

  • 15. Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis.
    Vogel F, Droszcz W, Vondra V, Reisenberg K, Marr C, Staley H.
    J Antimicrob Chemother; 1997 Dec; 40(6):863-71. PubMed ID: 9462439
    [Abstract] [Full Text] [Related]

  • 16. Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis.
    Langan C, Clecner B, Cazzola CM, Brambilla C, Holmes CY, Staley H.
    Int J Clin Pract; 1998 Dec; 52(5):289-97. PubMed ID: 9796558
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
    Siegert R, Gehanno P, Nikolaidis P, Bagger-Sjöbäck D, Ibanez JM, Hampel B, Sommerauer B.
    Respir Med; 2000 Apr; 94(4):337-44. PubMed ID: 10845431
    [Abstract] [Full Text] [Related]

  • 18. Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
    Klein GL, Whalen E, Echols RM, Heyd A.
    J Otolaryngol; 1998 Feb; 27(1):10-6. PubMed ID: 9511113
    [Abstract] [Full Text] [Related]

  • 19. Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis.
    Fogarty CM, Bettis RB, Griffin TJ, Keyserling CH, Nemeth MA, Tack KJ.
    J Antimicrob Chemother; 2000 Jun; 45(6):851-8. PubMed ID: 10837440
    [Abstract] [Full Text] [Related]

  • 20. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
    Henry DC, Kapral D, Busman TA, Paris MM.
    Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.